Form 4 for ARCT Arcturus Therapeutics Holdings Inc.
Accepted 2024-06-18 00:00:00 ET · period of report 2024-06-14 · accession 0001193805-24-000826 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-18 | 2024-06-14 | ARCT | Marquet Magda | Dir | M - OptEx | $0.00 | +3,131 | 3,131 | New | $0 |
| D | 2024-06-18 | 2024-06-14 | ARCT | Marquet Magda | Dir | M - OptEx | $0.00 | -3,131 | 0 | -100% | $0 |
| D | 2024-06-18 | 2024-06-14 | ARCT | Marquet Magda | Dir | A - Grant | $0.00 | +15.0K | 15.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-14 | M | A | 3,131 | $0.00 | 3,131 | D | — | — | (F1) Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024. |
| 2 | Derivative | Deferred Stock Units | 2024-06-14 | M | D | 3,131 | $0.00 | 0 | D | $0.00 · — to — | 3,131 Common Stock | (F2) Represents a portion of the 2023 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer. (F1) Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024. |
| 3 | Derivative | Stock option (right to buy) | 2024-06-14 | A | A | 15,000 | $0.00 | 15,000 | D | $31.00 · — to 2034-06-14 | 15,000 Common Stock | (F3) Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2024 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer. |